FUNDC1 and Sepsis: These findings suggest that FGF2 exerts its cardioprotective effects in septic cardiomyopathy by activating the AMPK–FUNDC1-mediated mitophagy pathway, thereby providing a potential therapeutic strategy for mitigating sepsis-induced cardiac damage.